Hartford Great Health Corp.
HFUS · OTC
7/31/2025 | 7/31/2024 | 7/31/2023 | 7/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.38 | 0.59 | -1.81 | 0.23 |
| FCF Yield | -0.01% | 0.77% | -0.14% | -6.44% |
| EV / EBITDA | 98.40 | 101.94 | -792.58 | -359.60 |
| Quality | ||||
| ROIC | 347.76% | 185.46% | 100.73% | 51.52% |
| Gross Margin | 94.60% | 96.04% | 0.00% | -20.64% |
| Cash Conversion Ratio | -0.01 | 0.79 | -0.31 | 0.49 |
| Growth | ||||
| Revenue 3-Year CAGR | – | 35.62% | -100.00% | 78.73% |
| Free Cash Flow Growth | -101.56% | 796.35% | 87.74% | 60.55% |
| Safety | ||||
| Net Debt / EBITDA | -0.04 | 3.22 | -37.38 | -79.97 |
| Interest Coverage | 390.56 | 49.77 | -6.95 | -158.02 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | -0.34 | -5.61 | 0.00 |
| Cash Conversion Cycle | -137.14 | -9,618.33 | -65.09 | 0.75 |